期刊文献+

心力衰竭超声心动图检查及生物标志物的研究进展

暂未订购
导出
摘要 各种心脏病患者终末期将发生心力衰竭(heart failure,HF)。据美国心肺血液研究所(NHLBI)统计,〉65岁的人群中HF发病率约为10.0%。而HF6年致残率在男性患者中为22.0%,女性患者中为46.0%。1993年至2003年.美国人群总死亡率下降2.0%,但其中HF病死率却上升了20.5%。HF患者的猝死发生率是普通人群的6-9倍。我国的HF患病率为0.9%,其中男性为0.7%,女性为1.0%.且随年龄增高,HF的患病率显著上升(P〈0.01)。
作者 卢佳艳 杜萱
出处 《诊断学理论与实践》 2008年第3期352-355,共4页 Journal of Diagnostics Concepts & Practice
  • 相关文献

参考文献30

  • 1[1]Thom T,Haase N,Rosamond W,et al.Heart disease and stroke statistics-2006 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee[J].Circulation,2006,113 (6):e85-151.
  • 2顾东风,黄广勇,吴锡桂,段秀芳,何江,Paul K Whelton,Stephen Mac Mahon.中国心力衰竭流行病学调查及其患病率[J].中华心血管病杂志,2003,31(1):3-6. 被引量:1295
  • 3[3]Bax JJ,Abraham T,Barold SS,et al.Cardiac resynchronization therapy part 1-Issues before device implantation[J].J Am Coll Cardiol,2005,46 (12):2153-2167.
  • 4[4]Zhang Q,Fung JW,Auricchio A,et al.Differential change in left ventricular mass and regional wall thickness after cardiac resynchronization therapy for heart failure[J].Eur Heart J,2006,27 (12):1423-1430.
  • 5[5]N.Van De Veire,G.B.Bleeker,J.De Sutter,et al.Tissue synchronisation imaging accurately measures left ventricular dyssynchrony and predicts response to cardiac resynchronisation therapy[J].Heart,2007,93 (9):1034-1039.
  • 6[6]Murdoch DR,McDonough TA,Byrne J,et al.Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration:randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy[J].Am Heart J,1999,138 (6 Pt 1):1126-1132.
  • 7[7]Latini R,Masson S,Anand I,et al.Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure:the Valsartan Heart Failure Trial (Val-HeFT)[J].Circulation.2002,106 (19):2454-2458.
  • 8[8]Maisel AS.The diagnosis of acute congestive heart failure:role of BNP measurements[J].Heart Fail Rev,2003,8 (4):327-334.
  • 9[9]Januzzi JL,van Kimmenade R,Lainchbury J,et al.NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure:an international pooled analysis of 1256 patients:the International Collaborative of NT-proBNP Study[J].Eur Heart J,2006,27 (3):330-337.
  • 10[10]Le Jemtel TH,Padeletti M,Jelic S.Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure[J].J Am Coll Cardiol,2007,49 (2):171-180.

二级参考文献63

  • 1吴薇,冯相平,陈新山.基质金属蛋白酶与心血管疾病及其法医学意义[J].中国法医学杂志,2005,20(1):37-40. 被引量:18
  • 2[1]Whitman M.Smads and early developmental signaling by the TGFbeta superfamily.Genes Dev,1998,12:2445-2462.
  • 3[2]Martina B,Martin L,Schechinger B,et.al.Characterization of the rat,mouse,and human genes of growth/differentiation factor-15/macrophage inhibiting cytokine-1 (GDF-15/MIC-1).Gene,1999,237:105-111.
  • 4[3]Vishwas MP,Vail AL,Grasser WA,et.al.Cloning and Characterization of a Novel Member of theTransforming Growth Factor-b/Bone Morphogenetic Protein Family.J Biol Chem,1998,273:13760-13767.
  • 5[4]Zimmers TA,Jin X,Hsiao EC,et.al.Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury.Shock,2005,23:543-548.
  • 6[5]Zimmers TA,Jin X,Hsiao EC,et.al.Growth differentiation factor-15:induction in liver injury through p53 and tumor necrosis factor-independent mechanisms.J Surg Res,2006,130(1):45-51.
  • 7[6]Cheung PK,Woolcock B,Adomat H,et.al.Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.Cancer Res,2004,64(17):5929-5933.
  • 8[7]Koopmann J,Buckhaults P,Brown DA,et al.Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.Clin Cancer Res,2004,10(7):2386-2392.
  • 9[8]Bootcov MR,Bauskin AR,Valenzuela SM,et.al.MIC-1,a novel macrophage inhibitory cytokine,is a divergent member of the TGF-b superfamily.Proc Natl Acad Sci USA,1997,94:11514-11519.
  • 10[9]Baek SJ,Kim KS,Nixon JB,et.al Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities.Mol Pharmacol,2001,59:901-908.

共引文献1309

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部